ArticleJournal of neurology2025

Relapse risk after rituximab discontinuation in neuromyelitis optica spectrum disorders: a multi-center retrospective cohort study.

Shengfei Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.